Skip to main content
OpenTrials
Completed

NCT Number: NCT03628807

Non-invasive Evaluation Program for TIPS and Follow Up Network

Evaluation of non-invasive prognostic parameters in patients receiving transjugular intrahepatic portosystemic shunt (TIPS) for complications of portal hypertension. Patients are cared according to the local standardized follow up program. Clinical and laboratory data from standard patient care are evaluated for potential prognostic value.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Portal Hypertension Digestive System Diseases Hypertension, Portal Liver Diseases

Age range

18 year–100 year

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospital Bonn

Bonn, Germany

About this study

NEPTUN consists of liver cirrhosis receiving transjugular intrahepatic portosystemic shunt (TIPS) at the Department of Internal Medicine I, University of Bonn, Germany and receiving a structured routine evaluation and follow up program. The diagnosis of cirrhosis was based on clinical, hemodynamic and biochemical parameters, and ultrasound and/or biopsy criteria.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Insertion of TIPS according to guidelines

Exclusion criteria

  • Contraindication for TIPS

Treatment and study plan

Primary outcomes

  1. Survival

    Time frame: up to 10 years

    death, liver transplantation

Secondary outcomes

  1. Ascites

    Time frame: up to 10 years

    Evaluation of amount of ascites according to the Child-Score

  2. Hepatic Encephalopathy

    Time frame: up to 10 years

    Evaluation of the grade according to the West Haven Criteria

  3. Variceal Bleeding

    Time frame: up to 10 years

    Assessment of presence of variceal bleeding

  4. Liver Failure

    Time frame: up to 10 years

    defined as Bilirubin level ≥ 12mg/dl

  5. Acute-on-Chronic-Liver Failure (ACLF)

    Time frame: up to 10 years

    Presence of ACLF according to the EASL-Chronic liver Failure Consortium (CLIF)-criteria

  6. Organ Failures

    Time frame: up to 10 years

    Assessment of Organ failures according to the CLIF-SOFA

    according to CLIF-Sequential Organ Failure Assessment (SOFA) Score

Sponsors and collaborators

Lead sponsor

University Hospital, Bonn

Other

Registry information

Official study title

Non-invasive Evaluation of Prognostic Parameters for Patients With Transjugular Intrahepatic Portosystemic Shunt (TIPS) Using a Structured Follow up Protocol

Acronym: NEPTUN

Important dates

Study start
1999
Primary completion
2020
Study completion
2020
First posted
Aug 14, 2018
Registry last updated
May 12, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.